U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C24H44O12
Molecular Weight 524.599
Optical Activity UNSPECIFIED
Defined Stereocenters 9 / 9
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SUCROSE, 1-LAURATE

SMILES

CCCCCCCCCCCC(=O)OC[C@@]2(O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)O[C@H](CO)[C@@H](O)[C@@H]2O

InChI

InChIKey=AYOPSBMGRBUJSJ-VQXBOQCVSA-N
InChI=1S/C24H44O12/c1-2-3-4-5-6-7-8-9-10-11-17(27)33-14-24(22(32)19(29)16(13-26)35-24)36-23-21(31)20(30)18(28)15(12-25)34-23/h15-16,18-23,25-26,28-32H,2-14H2,1H3/t15-,16-,18-,19-,20+,21-,22+,23-,24+/m1/s1

HIDE SMILES / InChI

Molecular Formula C24H44O12
Molecular Weight 524.599
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 9 / 9
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
Phospholipids-embedded fully dilutable liquid nanostructures. Part 2: The role of sodium diclofenac.
2010-12-01
Inactivation of Bacillus amyloliquefaciens spores by a combination of sucrose laurate and pressure-assisted thermal processing.
2010-11
Effects of non-ionic surfactants on in vitro triglyceride digestion and their susceptibility to digestion by pancreatic enzymes.
2010-10-09
Influence of stabilizer systems on the properties and phase behavior of supercooled smectic nanoparticles.
2010-10-01
Solubilization of poorly water-soluble drugs by mixed micelles based on hydrogenated phosphatidylcholine.
2010-08-16
Mixed micelle formation with phosphatidylcholines: the influence of surfactants with different molecule structures.
2010-03-15
Engineering of cyclodextrin glucanotransferases and the impact for biotechnological applications.
2010-01
A description of the structural determination procedures of a gap junction channel at 3.5 A resolution.
2009-08
Mathematical modeling of pH-surfactant-mediated solubilization of nimesulide.
2009-07
Lecithin based nanoemulsions: A comparative study of the influence of non-ionic surfactants and the cationic phytosphingosine on physicochemical behaviour and skin permeation.
2009-03-31
Inhibitory effects of sucrose fatty acid esters on survival of Yersinia enterocolitica on eggshell surface and use of blue lake as indicator of bacterial penetration into eggs.
2009-03
Screening of detergents for solubilization, purification and crystallization of membrane proteins: a case study on succinate:ubiquinone oxidoreductase from Escherichia coli.
2008-09-01
Analysis of survival rates and cellular fatty acid profiles of Listeria monocytogenes treated with supercritical carbon dioxide under the influence of cosolvents.
2008-09
Skin protection creams in medical settings: successful or evil?
2008-07-25
In vivo methods for the assessment of topical drug bioavailability.
2008-01
Clinical studies with oral lipid based formulations of poorly soluble compounds.
2007-08
Glucosylation of sucrose laurate with cyclodextrin glucanotransferase.
2007-03
Determination of regioisomeric distribution in carbohydrate fatty acid monoesters by LC-ESI-MS.
2007-02-05
Stabilization of interface-binding chloroperoxidase for interfacial biotransformation.
2007-01-30
Effect of high hydrostatic pressure on four genotypes of F-specific RNA bacteriophages.
2007-01
Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications.
2007
Cellular uptake of carotenoid-loaded oil-in-water emulsions in colon carcinoma cells in vitro.
2006-12-13
Purification of human beta2-adrenergic receptor expressed in methylotrophic yeast Pichia pastoris.
2006-12
Influence of sucrose esters on the in vivo percutaneous penetration of octyl methoxycinnamate formulated in nanocapsules, nanoemulsion, and emulsion.
2006-01
Skin permeation enhancement by sucrose esters: a pH-dependent phenomenon.
2005-06-13
PFGSE-NMR study of the self-diffusion of sucrose fatty acid monoesters in water.
2005-06-01
Delineation of ligand binding and receptor signaling activities of purified P2Y receptors reconstituted with heterotrimeric G proteins.
2004-12
Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo.
2004-06-18
Alkanoylsucroses in nasal delivery of low molecular weight heparins: in-vivo absorption and reversibility studies in rats.
2004-01
Direct evidence for expression of type II flavoprotein subunit in human complex II (succinate-ubiquinone reductase).
2003-11-21
Skin penetration and mechanisms of action in the delivery of the D2-agonist rotigotine from surfactant-based elastic vesicle formulations.
2003-10
Effects of sucrose oleate and sucrose laureate on in vivo human stratum corneum permeability.
2003-08
Rationalization of membrane protein crystallization with polyethylene glycol using a simple depletion model.
2003-05
Sucrose cocoate, a component of cosmetic preparations, enhances nasal and ocular peptide absorption.
2003-01-30
Binding and functional properties of the extrinsic proteins in oxygen-evolving photosystem II particle from a green alga, Chlamydomonas reinhardtii having his-tagged CP47.
2003-01
The in vivo and in vitro interactions of elastic and rigid vesicles with human skin.
2002-11-14
Efficient transesterification of sucrose catalysed by the metalloprotease thermolysin in dimethylsulfoxide.
2002-05-22
Keratolytic activity of microemulsions.
2001-12-04
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:33:07 GMT 2025
Edited
by admin
on Mon Mar 31 19:33:07 GMT 2025
Record UNII
Y81ELZ465K
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
.ALPHA.-D-GLUCOPYRANOSIDE, 1-DODECANOYL-.BETA.-D-FRUCTOFURANOSYL
Preferred Name English
SUCROSE, 1-LAURATE
Common Name English
.ALPHA.-D-GLUCOPYRANOSIDE, 1-O-DODECANOYL-.BETA.-D-FRUCTOFURANOSYL
Common Name English
.ALPHA.-D-GLUCOPYRANOSIDE, 1-O-(1-OXODODECYL)-.BETA.-D-FRUCTOFURANOSYL
Common Name English
.ALPHA.-D-GLUCOPYRANOSIDE, 1-LAUROYL-.BETA.-D-FRUCTOFURANOSYL
Common Name English
Code System Code Type Description
PUBCHEM
10311609
Created by admin on Mon Mar 31 19:33:07 GMT 2025 , Edited by admin on Mon Mar 31 19:33:07 GMT 2025
PRIMARY
CAS
136152-90-4
Created by admin on Mon Mar 31 19:33:07 GMT 2025 , Edited by admin on Mon Mar 31 19:33:07 GMT 2025
PRIMARY
EPA CompTox
DTXSID10159699
Created by admin on Mon Mar 31 19:33:07 GMT 2025 , Edited by admin on Mon Mar 31 19:33:07 GMT 2025
PRIMARY
FDA UNII
Y81ELZ465K
Created by admin on Mon Mar 31 19:33:07 GMT 2025 , Edited by admin on Mon Mar 31 19:33:07 GMT 2025
PRIMARY